Iqvia Holdings Inc.
IQVIA Inc. Announces €950M Senior Notes Offering
Summary
On June 3, 2026, IQVIA Holdings Inc. announced through its subsidiary, IQVIA Inc., its intention to raise €950,000,000 through an offering of senior notes due 2033. The proceeds will be used to refinance existing indebtedness and cover offering-related fees and expenses. The offering is subject to market and customary conditions. The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. without registration or an exemption.
Profitelligence Alerts
Get alerts for IQV
Be first to know when Iqvia Holdings Inc. files with the SEC.
Filing Categories
Advertisement
About Iqvia Holdings Inc.
Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.
Official SEC Documents
Advertisement